ISPOR Board Of Directors Election 2017-2018

Örömmel adunk tájékoztatást róla, hogy az International Society of Pharmacoeconomics and Outcomes Research (ISPOR) elnöki pozíciójára idén először kapott jelölést kelet-európai szakember. Kaló Zoltán egyike a két elnökjelöltnek, akikre az ISPOR tagok leadhatják szavazatukat.

ISPOR Vision Statement by Zoltán Kaló, MSc, MD, PhD

kalo_syreonSince my childhood, I have dreamt about building bridges between different stakeholders, regions, and cultures. I believe passionately that 1) policy-makers, researchers, and manufacturers have common objectives; 2) they must work together in a common framework to improve decision making for health globally, and 3) high-quality economic and outcomes research must be promoted equally in higher and lower income countries.

The tremendous success of ISPOR in recent years is built of the abovementioned principles. ISPOR is a rapidly growing scientific organization with strong track record of building bridges between different stakeholders, regions, and cultures. More and more participants of ISPOR conferences are from lower income countries. My nomination for ISPOR presidency proves that leaders of our society are paying attention to emerging economies. I fully support the vision and mission of the society, and I am honored to be the first candidate from Central and Eastern Europe for the ISPOR Presidency.

My ambition for the ISPOR Presidency is to promote collaborative research, education, and application of common principles and practices between higher and lower income countries across different regions. I am committed to expedite patient empowerment in global and local health care policy and to strengthen collaboration with other global organizations and scientific societies. In higher income countries, I would like to facilitate the establishment of local ISPOR chapters and engagement of policy makers with ISPOR initiatives and events. In emerging economies, I plan to support capacity building in health economics and outcomes research, and facilitate the transparency, objectivity, and appropriateness of allocation of scarce health care resources. Finally, in lower income countries, I will work actively to mobilize and engage skilled health economists and outcomes researchers so we can all benefit from their plenary presentations at major international conferences and increasing publications in high-impact journals.

Regardless of the outcome of my candidacy, I am dedicated to support implementation of ISPOR Strategic Plan 2016–2020.